WALTHAM, Massachusetts, March 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its February 2024 edition (Vol. 3, No. 2):

Original Articles:

* Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer

* Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:

What's your Affiliation

Government Newspaper / Media Business Public Policy Individual / Student Educators

Email:

Phone:

Organization, if any:

State/Country you are in:

Additional questions or comments:

Submit Form Click here for more information about our products